To detect myeloma-specific vulnerabilities, genes were filtered by their median dependency in myeloma versus nonmyeloma cell lines applying a cutoff based on the lenalidomide targets IKZF1 and IKZF3 (refs. 39,40). The gene discussed is IKZF3; the disease is plasma cell myeloma.